4,507 results match your criteria: "JAMA surgery[Journal]"
Best Practices for Big Data Sources and Methods in Surgery.
JAMA Surg
January 2025
Departments of Surgery and Biomedical Engineering, University of Virginia School of Medicine, Charlottesville.
Practical Guide to Image-Based Big Data Research.
JAMA Surg
January 2025
Department of Surgery, Stanford University School of Medicine, Palo Alto, California.
Practical Guide to Clinical Big Data Sources.
JAMA Surg
January 2025
Department of Surgery, Veterans Affairs Boston Health Care System, Boston, Massachusetts.
Practical Guide to Patient-Generated Data Sources.
JAMA Surg
January 2025
Department of Surgery, Amsterdam University Medical Centers, Amsterdam, the Netherlands.
Practical Guide to Multiomics Big Data Sources.
JAMA Surg
January 2025
Bitterroot Bio, Palo Alto, California.
Practical Guide to Artificial Intelligence, Chatbots, and Large Language Models in Conducting and Reporting Research.
JAMA Surg
January 2025
Department of Surgery, University of Florida Health, Gainesville.
Practical Guide to Use of Simulation and Video Data.
JAMA Surg
January 2025
Department of Surgery, Stanford University, Stanford, California.
Silent Cost of Private Equity Hospitals.
JAMA Surg
January 2025
Division of Thoracic Surgery, St Elizabeth's Medical Center, Brighton, Massachusetts.
De-Escalation of Nodal Surgery in Clinically Node-Positive Breast Cancer.
JAMA Surg
January 2025
Breast Unit, Department of General Surgery, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Türkiye.
Importance: Increasing evidence supports the oncologic safety of de-escalating axillary surgery for patients with breast cancer after neoadjuvant chemotherapy (NAC).
Objective: To evaluate the oncologic outcomes of de-escalating axillary surgery among patients with clinically node (cN)-positive breast cancer and patients whose disease became cN negative after NAC (ycN negative).
Design, Setting, And Participants: In the NEOSENTITURK MF-1803 prospective cohort registry trial, patients from 37 centers with cT1-4N1-3M0 disease treated with sentinel lymph node biopsy (SLNB) or targeted axillary dissection (TAD) alone or with ypN-negative or ypN-positive disease after NAC were recruited between February 15, 2019, and January 1, 2023, and evaluated.
Increasing Enrollment of Women in Surgical Clinical Trials.
JAMA Surg
January 2025
Departments of Surgery and Biomedical Engineering, University of Virginia School of Medicine, Charlottesville.
Esophagectomy Trends and Postoperative Outcomes at Private Equity-Acquired Health Centers.
JAMA Surg
January 2025
Department of Surgery, University of Michigan, Ann Arbor.
Article Synopsis
- This study investigates the impact of private equity acquisition on the quality of care for patients undergoing esophagectomy in US hospitals.
- It compares patient outcomes, specifically focusing on 30-day postoperative complications and mortality, between private equity-acquired hospitals and nonacquired facilities.
- Findings reveal that patients at private equity-acquired hospitals have higher mortality rates and lower annual surgical procedure volumes compared to those at nonacquired hospitals.
Not Time to Abandon Cholecystectomy for Symptomatic Cholelithiasis-Reply.
JAMA Surg
December 2024
Department of Surgery, Radboud University Medical Centre, Nijmegen, the Netherlands.
Frailty and Long-Term Health Care Utilization After Elective General and Vascular Surgery.
JAMA Surg
December 2024
Department of Surgery, Stanford University School of Medicine, Stanford, California.
Importance: Surgical quality improvement efforts have largely focused on 30-day outcomes, such as readmissions and complications. Surgery may have a sustained impact on the health and quality of life of patients considered frail, yet data are lacking on the long-term health care utilization of patients with frailty following surgery.
Objective: To examine the independent association of preoperative frailty on long-term health care utilization (up to 24 months) following surgery.
Anterior Gastropexy for Paraesophageal Hernia Repair: A Randomized Clinical Trial.
JAMA Surg
December 2024
Cleveland Clinic Center for Abdominal Core Health, Department of General Surgery, Digestive Disease and Surgery Institute, The Cleveland Clinic Foundation, Cleveland, Ohio.
Importance: Paraesophageal hernias can cause severe limitations in quality of life and life-threatening complications. Even though minimally invasive paraesophageal hernia repair (MIS-PEHR) is safe and effective, anatomic recurrence rates remain notoriously high. Retrospective data suggest that suturing the stomach to the anterior abdominal wall after repair-an anterior gastropexy-may reduce recurrence, but this adjunct is currently not the standard of care.
View Article and Find Full Text PDFThe Investigational Device Exemption Effect-More Than Just Volume.
JAMA Surg
December 2024
Division of Vascular Surgery and Endovascular Therapy, The University of Alabama at Birmingham.
Fenestrated and Branched Endovascular Aortic Repair and Mortality at Hospitals Without Investigational Device Trials.
JAMA Surg
December 2024
Division of Vascular Surgery and Endovascular Therapy, Johns Hopkins University, Baltimore, Maryland.
Importance: Fenestrated and branched endovascular aortic repairs (F/BEVAR) have been adopted by many centers. However, national trends of F/BEVAR use remain unclear, particularly at sites who perform them without an US Food and Drug Adminstration (FDA)-approved investigational device exemption (IDE).
Objective: To quantify the use of F/BEVAR in the US and to determine if mortality was different at IDE vs non-IDE sites.
Not Time to Abandon Cholecystectomy for Symptomatic Cholelithiasis.
JAMA Surg
December 2024
Department of General Surgery, Cleveland Clinic Foundation, Cleveland, Ohio.
US Centers for Medicare and Medicaid Services Policy Shift.
JAMA Surg
December 2024
Division of Vascular and Endovascular Surgery, Department of Surgery, University of California, San Diego, La Jolla, California.